A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Muscular Dystrophy, Duchenne
Interventions
DRUG

Eteplirsen

Solution for intravenous (IV) infusion.

Trial Locations (59)

1000

University Medical Centre Ljubljana, Ljubljana

1010

New Zealand Clinical Research - Auckland, Auckland

1082

Semmelweis Egyetem Genomikai Medicina és Ritka Betegsegek Intezete, Budapest

2100

Rigshospitalet Copenhagen University Hospital, Copenhagen

4011

Children's Department and Department for Children's Habilitation at Stavanger University Hospital, Stavanger

4031

Universitätsspital Basel, Basel

6351

Samsung Medical Center, Seoul

8950

Hospital Sant Joan de Deu, Barcelona

10071

National Taiwan University Hospital, Taipei

11000

Clinic for Neurology and Psychiatry for Children and Youth, Belgrade

University Children's Hospital, Belgrade

11194

The Specialty Hospital (TSH)/Advanced Clinical Center, Amman

11196

Istiklal Hosptial (IST), Amman

13353

Charité Universitätsmedizin Berlin CVK, Berlin

16147

IRCCS Instituto Gianna Gaslini, Genova

22110

Irbid Specialty Hospital, Irbid

Pharmaceutical Research Center/Jordan University of Science and Technology, Irbid

30318

Rare Disease Research, LLC, Atlanta

33110

Mersin University Medical Faculty, Mersin

34000

Instituto de Investigaciones Clinicas para la Salud A.C, Durango

35233

University of Alabama at Birmingham, Birmingham

41404

Kyungpook National University Chilgok Hospital, Daegu

41408

"National Clinical Hospital for Children Neurorehabilitation Dr. Nicolae Robănescu", Bucharest

45147

Universitätsklinikum Essen, Essen

46026

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

50012

Instituto Neurologico de Colombia (INDEC), Medellín

50034

Hospital Pablo Tobón Uribe, Medellín

50612

Pusan National University Yangsan Hospital, Yangsan

67098

CHRU de Strasbourg, Strasbourg

69677

Hopital Femme Mere Enfant, Bron

75571

Hopital Armand Trousseau, Paris

79106

Universitätsklinikum Freiburg, Freiburg im Breisgau

80020

Neurociencias Estudios Clínicos S.C., Culiacán

80756

Kaohsiung Medical University, Kaohsiung City

110029

All India Institute of Medical Sciences, New Delhi

110060

Sir Ganga Ram Hospital, New Delhi

110231

Hospital Universitario San Ignacio, Bogotá

190133

"Mother and Child Health Care Institute of Serbia Dr Vukan Cupic", Belgrade

380054

Royal Institute of Child Neurosciences, Ahmedabad

411004

Deenanath Mangeshkar Hospital & Research Centre, Pune

500082

Nizam's Institute of Medical Sciences, Hyderabad

560078

Aster RV Hospital, Bengaluru

626022

Jaicare Hospital (A Unit of Sarvee Integra Pvt Ltd.), Madurai

632004

Christian Medical College, Vellore

32610-3010

University of Florida, Gainesville

613 00

Brno Klinika detske neurologie, Brno

150 06

Fakultni nemocnice v Motole, Prague

151 23

IASO Children's Hospital, Marousi

D01 XD99

Children's Health Ireland (CHI) at Temple Street, Dublin

00168

Fondazione Policlinico Universitario A. Gemelli- IRCCS, Rome

2333 ZC

Leids Universitair Medisch Centrum, Leiden

6525GA

Radboud University Nijmegen Medical Centre, Nijmegen

0450

Oslo Universitetssykehus HF Rikshospitalet, Oslo

80-211

Klinika Neurologii Rozwojowej, Gdansk

03080

Seoul National University Hospital, Seoul

07059

Akdeniz Universitesi Tip Fakultesi, Antalya

LS1 3EX

Leeds Teaching Hospitals NHS Trust, Leeds

B9 5SS

Birmingham Heartlands Hospital, Birmingham

WC1N 1EH

UCL Institute of Child Health Great Ormond Street, London

All Listed Sponsors
lead

Sarepta Therapeutics, Inc.

INDUSTRY